VitriVax
Thermostable single-shot vaccination formulation platform
- Sector
- Biotech
- Headquarters
- BOULDER, CO
- Latest Form D
- $29.4M, Nov 2025
- Total capital
- $43.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $29.4M
- 1 Form D · last Nov 2025
- 11 months since last filing
- Federal contracts
- $14.5M
- 1 award · Defense
- Rank in Biotech#51 of 4373
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$29.4M
- Federal contractDefense · Optimization And Production Of Single-shot Vaccines For Melioidosis And Glanders$14.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
34months
from VitriVax’s first federal award to its first private round.
- First federal award · Jan 2023
- Defense · $14.5M
- First Form D · Nov 2025
- $29.4M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Founders and team
From SEC Form D filings- Glenn RockmanDirectorNamed in SEC Form D filings
- Louise BradyDirectorNamed in SEC Form D filings
- Rene LorenzDirectorNamed in SEC Form D filings
- Romulo ColindresExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Theodore RandolphDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 6- PendingCompositions, Methods, And Uses For Polynucleotide Formulations For Drying And Prolonged StorageUSPTOApplication 19273245
- PendingCompositions, Methods And Uses For Determining Atomic Layer Deposition Coating Quality And Dissolution RatesUSPTOApplication PCTUS2024058293
- PendingCompositions, Methods, And Uses For Polynucleotide Formulations For Drying And Prolonged StorageUSPTOApplication PCTUS2024012635
Show all 6 patent records
- Compositions, Methods, And Uses For Polynucleotide Formulations For Drying And Prolonged StorageJan 15, 2026 · Application 19273245Pending
- Compositions, Methods And Uses For Determining Atomic Layer Deposition Coating Quality And Dissolution RatesApplication PCTUS2024058293Pending
- Compositions, Methods, And Uses For Polynucleotide Formulations For Drying And Prolonged StorageApplication PCTUS2024012635Pending
- Compositions, Methods And Uses For Determining Atomic Layer Deposition Coating Quality And Dissolution RatesApplication 63605994Pending
- Compositions, Methods And Uses For Polynucleotide Formulations For Drying And StorageApplication 63529599Pending
- Chemical Vapor Deposition Device With Adherence Disruption Feature And Methods Of Using The SameApplication PCTUS2023063738Pending
Related companies, and why
- REPLIGEN CORPSimilar federal contract value in Biotech · $14.9M in contracts
- AUTOIMMUNE TECHNOLOGIES, LLCSimilar federal contract value in Biotech · $14.8M in contracts
- BLUEWILLOW BIOLOGICS INCSimilar federal contract value in Biotech · $14.7M in contracts
- HDT BIO CORPSimilar federal contract value in Biotech · $14.5M in contracts
- ENALARE THERAPEUTICS INCSimilar federal contract value in Biotech · $13M in contracts
- INIMMUNE CORPSimilar federal contract value in Biotech · $12.8M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .